Skip to content

NOVO70

Novolin 70/30 vial. 10ml

NOVO70 Novolin 70/30 vial. 10ml is a premixed insulin with 70% NPH and 30% regular insulin, priced at $45.63. Ideal for adults and children with type 1 or type 2 diabetes needing balanced blood sugar control, it offers dual-action insulin delivery for mealtime and basal coverage in one injection.

$45.63 $58.95-23%

● In stock

Buy at Diabetesstore.com →

Price and availability may change. Click to see current details on Diabetesstore.com.

Key features

  • 70% NPH, 30% regular insulin blend
  • Onset in 30 minutes (regular) and 1–2 hours (NPH)
  • Peaks at 2–3 hours (regular), 4–12 hours (NPH)
  • Lasts up to 24 hours for full-day control
  • 10ml multi-dose vial for repeated use
  • Compatible with standard insulin syringes
  • Refrigeration required before first use

Pros

  • +Balances mealtime and basal insulin needs
  • +Reduces number of daily injections
  • +Cost-effective compared to analog insulins
  • +Well-established formulation with predictable action
  • +Suitable for both type 1 and type 2 diabetes
!

Cons

  • Requires meal timing coordination
  • Less flexible than rapid-acting analogs
  • Risk of hypoglycemia if meals delayed
  • Must be kept cool during shipping

About NOVO70 Novolin 70/30 vial. 10ml

What is NOVO70 Novolin 70/30 vial. 10ml?

NOVO70 Novolin 70/30 vial. 10ml is a premixed human insulin formulation designed for managing diabetes mellitus in both adults and children. Each 10ml vial contains 70% NPH insulin (intermediate-acting) and 30% regular insulin (short-acting), providing a dual-action profile that supports both mealtime glucose control and sustained basal insulin levels. This combination simplifies insulin therapy by reducing the need for multiple injections, making it a practical choice for patients requiring consistent blood sugar management throughout the day.

Key features

  • 70/30 Premix — Combines 70% NPH and 30% regular insulin for balanced coverage.
  • Onset Time — Regular insulin starts working in 30 minutes; NPH in 1–2 hours.
  • Peak Action — Regular peaks at 2–3 hours; NPH peaks between 4–12 hours.
  • Duration — Effective up to 24 hours, supporting full-day glucose control.
  • Dosage Flexibility — Tailored dosing allows individualized diabetes management.
  • Vial Format — 10ml multi-dose vial compatible with standard insulin syringes.
  • Storage — Requires refrigeration before use; stable at room temperature after first use.

Who is NOVO70 Novolin 70/30 vial. 10ml for?

This insulin is intended for individuals with type 1 or type 2 diabetes who require both basal and bolus insulin coverage. It's especially beneficial for those who prefer fewer injections and need reliable, predictable glucose control around meals and between meals. It may be prescribed to patients transitioning from other premixed insulins or those struggling with complex regimens.

How does NOVO70 Novolin 70/30 vial. 10ml compare?

Compared to long-acting insulins like glargine or detemir, NOVO70 provides both immediate and extended action but requires more precise timing with meals. Unlike rapid-acting analogs, its onset is slower, making it less ideal for post-meal dosing. However, as a cost-effective premixed option, it offers a simpler alternative to multiple daily injections of separate basal and bolus insulins, especially for patients prioritizing affordability and regimen simplicity over peak flexibility.

🎯

Best use cases

  • Managing post-meal blood sugar spikes
  • Simplifying insulin regimens for elderly patients
  • Basal-bolus coverage in one injection
  • Cost-conscious diabetes treatment plans
  • Patients transitioning from other 70/30 insulins
🛒

Is Novolin 70/30 vial. 10ml right for you?

NOVO70 Novolin 70/30 vial is best for individuals with type 1 or type 2 diabetes who need a reliable, affordable premixed insulin. Suitable for beginners and experienced users, it works well for those who prefer fewer injections and can time meals with insulin peaks. Consider alternatives like insulin pens or analogs if you need more dosing flexibility or faster onset.

How it compares: Compared to rapid-acting insulins, NOVO70 has a slower onset and requires meal planning. Versus long-acting basal insulins, it offers meal coverage but less steady background control. As a premix, it's simpler than split regimens but less customizable than using separate insulins.

More from Diabetesstore.com

?

Frequently Asked Questions

What is NOVO70 Novolin 70/30 used for?

NOVO70 Novolin 70/30 is used to manage blood sugar in people with type 1 or type 2 diabetes. The 70/30 blend provides both immediate and extended insulin action, helping control glucose levels after meals and between meals when taken as directed.

Does NOVO70 require refrigeration?

Unopened vials must be refrigerated. Once in use, the vial can be kept at room temperature for up to 28 days. Avoid freezing or exposure to extreme heat or light to maintain insulin effectiveness.

How do I inject NOVO70 Novolin 70/30?

Use a standard insulin syringe to draw from the vial after gently rolling it to mix the insulin. Inject subcutaneously 30 minutes before a meal. Always follow your healthcare provider's dosing and injection instructions.

Is NOVO70 the same as other 70/30 insulins?

NOVO70 contains the same 70/30 mix of NPH and regular insulin as other human premixed insulins. It is therapeutically equivalent to other Novolin 70/30 formulations, though brand and packaging may differ.

Can I travel with NOVO70 insulin?

Yes, but keep it cool during transit using a medical cooling bag. Avoid temperature extremes. Carry it in your carry-on luggage and have a prescription handy for airport security checks.

How much does Novolin 70/30 vial. 10ml cost?

Novolin 70/30 vial. 10ml is $45.63 at Diabetesstore.com, marked down from $58.95 (save 23%). Prices may change — click through to Diabetesstore.com for the latest.

Is Novolin 70/30 vial. 10ml in stock at Diabetesstore.com?

Yes, Novolin 70/30 vial. 10ml is currently in stock at Diabetesstore.com.

Specifications

Brand
NOVO70
SKU
49771
Last updated May 14, 2026